Jiangsu Changhai Composite Materials Co., Ltd (300196.SZ)
Changzhou, CN
Jiangsu Changhai Composite Materials Co., Ltd is a comprehensive enterprise dedicated to the research, development, manufacturing, sales, and support of fiberglass-based composite materials. The company offers a wide array of products, starting with various resins, including unsaturated polyester resins. Its extensive product line features numerous fiberglass reinforcements, such as those specifically engineered for printed circuit boards (PCBs) and battery separators, alongside different types of rovings like assembled, panel, sheet molding compound (SMC), and woven varieties. They also produce rovings for chopped strand mats and pultrusion, as well as fiberglass wet chopped strands. Further offerings include coated tissues designed for polyurethane foams, woven meshes, chopping rovings utilized in headliners, and both standard and lightweight chopped strand mats. Their non-woven segment encompasses coated tissues for gypsum sheathing, various tissues for wall coverings, carpet tiles, pipes, and roofing applications, in addition to surfacing veils. The portfolio also extends to battery separators, combotex roving, continuous fiber-reinforced thermoplastic tapes, specific assembled and direct rovings for thermoplastics, and bulk molding compound (BMC) products. Moreover, a range of chemical derivatives such as hydroxypropyl methacrylate, hydroxyethyl methacrylate (HEMA), hydroxypropyl acrylate (HPA), and hydroxyethyl acrylate (HEA) are produced. These diverse materials find application across numerous sectors, including automotive manufacturing, marine vessels (yachts), private facilities, storage tanks, pipeline coatings, cooling towers, and architectural decoration. Established in Changzhou, China, in 2000, Jiangsu Changhai Composite Materials has cultivated a significant international presence, distributing its products to approximately 30 countries and regions globally, including markets in North America, South America, Europe, the Middle East, Southeast Asia, Oceania, and Africa, complementing its strong domestic sales in China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+17.7% ★ Q1'26: -3.8% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+17.9% ★ Q1'26: +0.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-9.9% Q1'26: -13.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+11.5% ★ Q1'26: +13.5% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.5% ★ Q1'26: +8.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+7.1% Q1'26: -1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.76× ★ Q1'26: 1.75× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.52B
est: 1.53B (-0.7%)
|
1.77B
est: 2.01B (-12.2%)
|
2.03B
est: 2.07B (-2.0%)
|
2.20B
est: 2.20B (0.0%)
|
2.21B
est: 2.33B (-5.3%)
|
2.04B
est: 2.15B (-5.0%)
|
2.82B
est.
|
2.51B
est: 3.04B (-17.6%)
|
3.02B
est: 2.52B (+19.6%)
|
2.61B
est: 2.52B (+3.3%)
|
2.66B
est: 2.59B (+2.7%)
|
3.13B
est: 3.09B (+1.3%)
|
3.49B
3.41B – 3.57B
+12.8% YoY
|
4.03B
3.85B – 4.20B
+15.4% YoY
|
4.64B
4.48B – 4.79B
+15.1% YoY
|
| EBITDA |
384.27M
est: 409.64M (-6.2%)
|
448.29M
est: 540.37M (-17.0%)
|
365.69M
est: 555.40M (-34.2%)
|
446.64M
est: 590.03M (-24.3%)
|
480.69M
est: 626.32M (-23.3%)
|
464.04M
est: 577.37M (-19.6%)
|
757.00M
est.
|
816.08M
est: 816.23M (0.0%)
|
1.05B
est: 665.49M (+57.4%)
|
593.40M
est: 665.49M (-10.8%)
|
569.47M
est: 683.79M (-16.7%)
|
640.25M
est: 815.49M (-21.5%)
|
920.09M
899.18M – 941.00M
+12.8% YoY
|
1.06B
1.02B – 1.11B
+15.4% YoY
|
1.22B
1.18B – 1.26B
+15.1% YoY
|
| EBIT |
283.21M
est: 297.65M (-4.9%)
|
335.08M
est: 392.64M (-14.7%)
|
250.23M
est: 403.56M (-38.0%)
|
314.74M
est: 428.72M (-26.6%)
|
336.80M
est: 455.09M (-26.0%)
|
311.86M
est: 419.52M (-25.7%)
|
550.04M
est.
|
661.79M
est: 593.09M (+11.6%)
|
856.40M
est: 473.84M (+80.7%)
|
374.44M
est: 473.84M (-21.0%)
|
351.42M
est: 486.87M (-27.8%)
|
361.50M
est: 580.65M (-37.7%)
|
655.12M
640.23M – 670.01M
+12.8% YoY
|
756.16M
723.92M – 788.40M
+15.4% YoY
|
870.55M
841.33M – 899.77M
+15.1% YoY
|
| Net Income |
213.54M
est: 248.71M (-14.1%)
|
257.63M
est: 286.97M (-10.2%)
|
201.94M
est: 260.48M (-22.5%)
|
263.08M
est: 273.73M (-3.9%)
|
289.45M
est: 318.76M (-9.2%)
|
270.69M
est: 326.71M (-17.1%)
|
607.06M
est.
|
572.41M
est: 841.05M (-31.9%)
|
817.31M
est: 221.32M (+269.3%)
|
296.08M
est: 221.32M (+33.8%)
|
274.78M
est: 326.41M (-15.8%)
|
326.44M
est: 408.59M (-20.1%)
|
461.54M
454.13M – 481.79M
+13.0% YoY
|
581.39M
543.06M – 599.38M
+26.0% YoY
|
650.31M
631.10M – 669.53M
+11.9% YoY
|
| SGA |
202.03M
est: 28.90M (+599.2%)
|
230.73M
est: 38.12M (+505.3%)
|
188.60M
est: 39.18M (+381.4%)
|
201.95M
est: 41.62M (+385.2%)
|
215.18M
est: 44.18M (+387.0%)
|
163.54M
est: 40.73M (+301.5%)
|
53.40M
est.
|
148.86M
est: 57.58M (+158.5%)
|
170.71M
est: 138.35M (+23.4%)
|
184.98M
est: 138.35M (+33.7%)
|
194.33M
est: 142.15M (+36.7%)
|
44.49M
est: 169.53M (-73.8%)
|
191.27M
186.93M – 195.62M
+12.8% YoY
|
220.77M
211.36M – 230.19M
+15.4% YoY
|
254.17M
245.64M – 262.70M
+15.1% YoY
|
| EPS |
0.56
est: 0.56 (-0.6%)
|
0.65
est: 0.65 (+0.0%)
|
0.48
est: 0.59 (-18.6%)
|
0.63
est: 0.62 (+1.6%)
|
0.71
est: 0.72 (-1.7%)
|
0.66
est: 0.74 (-10.8%)
|
1.38
est.
|
1.40
est: 1.91 (-26.5%)
|
2.00
est: 0.50 (+297.1%)
|
0.72
est: 0.50 (+42.9%)
|
0.68
est: 0.75 (-9.3%)
|
0.81
est: 0.93 (-12.4%)
|
1.07
1.03 – 1.10
+15.1% YoY
|
1.30
1.24 – 1.36
+22.1% YoY
|
1.48
1.44 – 1.52
+13.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 349.2K | 0.06% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 46.4K | 0.46% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 179.2K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 87.5K | 0.29% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 10.7K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 24.1K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.19M | 0.06% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 66.0K | 0.28% |
| 9 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.21M | 0.05% |
| 10 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 1.9K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ji Xing Qi | Deputy General Manager | — | male |
| Li Ping Shao | Deputy GM & Non-Independent Director | — | female |
| Peng Wei Yang | GM & Director | — | male |
| Weibing Fei | Vice President & Board Secretary | — | male |
| Xixu Zhou | Accounting Supervisor, Chief Financial Officer & Non-Independent Director | — | male |
| Zhou Yuanlong | Deputy GM & Non-Independent Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300196.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
